Ipamorelin is a selective growth hormone secretagogue peptide commonly studied in laboratory environments for its interaction with GHS receptors and associated endocrine signalling pathways

100% fees at risk* 0% GLP-1 for weight loss trend guarantee 8% bodyweight reduction, with or without GLP-1 medications More than just marketing claims, validated weight loss results Years of nutrition-first care, medication management, and GLP-1 deprescription when clinically appropriate Learn about our approach Weight loss without drugs View our outcomes Sustained weight loss a year after GLP-1 deprescription See the results How it works Easy implementation via PBM integrations enables guardrails without rebate impact Navigate members to Virtas effective care via our PBM integrations and member communications Educate on the benefits of Nutrition Therapy and guide each member to the right care with or without GLP-1s Adapt nutrition and behavioral care to each member based on lifestyle, metabolism, and continuous health data Maximize success for those on GLP-1s with provider-led effective titration, side-effect support, and engagement monitoringno wasted spend on off-label prescriptions or ineffective anti-obesity medications

Early real-world data suggest promising results in post-bariatric patients, though formal trials are limited
For a budget-friendly program, it feels surprisingly personal and straightforward
Theres no reason to believe that the increased mitochondrial biogenesis, the activation of mitochondrial proteins, the antioxidant enzyme production are not happening to some degree, even with the smallest levels of GLP-1s, he says
Peak Wellness does not accept insurance